Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | TFPI | P10646 | 4/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.55 |
| ▸ | NPY2R | P49146 | 3/20 | 0.54 |
| ▸ | NPY4R | P50391 | 3/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.54 |
| ▸ | NPY1R | P25929 | 2/20 | 0.54 |
| ▸ | GLP1R | P43220 | 1/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607307 | 0.90 | OPRM1 (0.57) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30658338 | 0.89 | CALCR (0.63) | CALCRKEAP1NPY2RNPY4RNPY5R | |
| SCHEMBL30887555 | 0.88 | CALCR (0.66) | CALCRTFPIKEAP1NPY2RNPY4R | |
| SCHEMBL30393126 | 0.88 | OPRM1 (0.50) | TFPIKEAP1MAPK8MAPK9MAPK10 | |
| SCHEMBL30358175 | 0.88 | CALCR (0.62) | CALCRTFPIKEAP1NPY2RNPY4R | |
| SCHEMBL30565140 | 0.88 | CALCR (0.68) | CALCRKEAP1GLP1R | |
| SCHEMBL30565138 | 0.88 | CALCR (0.68) | CALCRKEAP1GLP1R | |
| SCHEMBL30567755 | 0.87 | NPY2R (0.59) | CALCRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29555982 | 0.87 | OPRM1 (0.50) | TFPIKEAP1MAPK8MAPK9MAPK10 | |
| SCHEMBL30028547 | 0.87 | CALCR (0.65) | CALCRTFPIKEAP1NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| US-11851644-B2 | Marine bacteria formulation useful in aquaculture | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2023-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CALCR 118/4885RXFP1 111/4885TFPI 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.